Investor Relations

SEC Filings

Document Details

Form
Filing Date
May 22, 2026
Document Date
May 04, 2026
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.